Jin Medical International Ltd. (NASDAQ:ZJYL - Get Free Report) was the recipient of a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 1,090,000 shares, a decline of 59.6% from the October 15th total of 2,700,000 shares. Currently, 2.9% of the shares of the company are sold short. Based on an average daily volume of 279,000 shares, the short-interest ratio is currently 3.9 days.
Jin Medical International Stock Up 0.3 %
ZJYL traded up $0.01 during trading hours on Wednesday, hitting $1.45. The company's stock had a trading volume of 375,214 shares, compared to its average volume of 373,140. The company has a 50-day simple moving average of $2.43 and a 200 day simple moving average of $2.84. Jin Medical International has a fifty-two week low of $0.45 and a fifty-two week high of $25.49.
About Jin Medical International
(
Get Free Report)
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.
Recommended Stories
Before you consider Jin Medical International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jin Medical International wasn't on the list.
While Jin Medical International currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.